|
|
Article: GENova Bio ends relationship with Bridge BioResearch.
- Article from:
- Biotech Week
- Article date:
- October 7, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova") announced that it has ceased the relationship with Bridge BioResearch PLC and unconditionally retract the announcement made earlier this month and GENova further announced that Mr. Anders Bogh Jensen, Chief Science Officer of Bridge BioResearch PLC, will not be serving on the GENova's Scientific Advisory Board (see also Genova Biotherapeutics, Inc., 1-646-845-1920, info@genovabio.com).
About GENova Biotherapeutics Inc.
GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt ...